Annual report pursuant to Section 13 and 15(d)

License Agreements, Clinical Research Support Agreements and Sponsored Research Agreements (Tables)

v3.8.0.1
License Agreements, Clinical Research Support Agreements and Sponsored Research Agreements (Tables)
 12 Months Ended
Dec. 31, 2017
License Agreement Disclosure [Abstract]  
Research and Development Arrangement, Contract to Perform for Others [Table Text Block]
For the years ended December 31, 2017, 2016, and 2015 the Company recorded the following expense in research and development for licenses acquired:
 
 
 
For the year ended December 31,
 
For the period from
March 13, 2015
(Inception) to
December 31,
 
($ in thousands)
 
2017
 
2016
 
2015
 
City of Hope
 
 
 
 
 
 
 
 
 
 
CAR T
 
$
-
 
$
1,683
 
$
2,147
 
IL13Rα2
 
 
500
 
 
-
 
 
-
 
IV/ICV
 
 
125
 
 
-
 
 
-
 
PSCA
 
 
300
 
 
-
 
 
-
 
HER2
 
 
600
 
 
-
 
 
-
 
CS-1
 
 
600
 
 
-
 
 
-
 
Harvard University - CRISPR
 
 
250
 
 
-
 
 
-
 
Fortress PIK Dividend
 
 
9,558
 
 
4,396
 
 
190
 
UCLA - PSCA
 
 
200
 
 
-
 
 
-
 
Fred Hutch - CD20
 
 
300
 
 
-
 
 
-
 
Total
 
$
12,433
 
$
6,079
 
$
2,337